Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doravirine switch in HIV patients with NNRTI resistance
NCT04334551Phase 4Unknown
- Sponsor
- Clinique du Quartier Latin
- Start
- Jun 2020
- Primary completion
- Jul 2022
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 4 trial of doravirine in human immunodeficiency virus infection (HIV), sponsored by Clinique du Quartier Latin. Status: unknown.
02
Drugs
doravirine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT04334551.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04334551.